Title
Author
DOI
Article Type
Special Issue
Volume
Issue
Expression of beclin 1, an autophagy-related protein, in human cervical carcinoma and its clinical significance
1Department of Obstetrics and Gynecology, Qingdao Central Hospital, Qingdao, Shandong, P. R. China
2Department of Gynecology, Cancer Center, Sun Yat-Sen University, Guangzhou, Guangdong, P. R. China
3Department of Pathology, Cancer Center, Sun Yat-Sen University, Guangzhou, Guangdong, P. R. China
*Corresponding Author(s): Y.N. ZHANG E-mail: zhangyannapds@163.com
Purpose: To investigate the impact of beclin 1 on prognosis of cervical cancer, we determined the expression of beclin 1 in cervical cancer, cervical intraepithelial neoplasia (CIN) and normal cervical tissues. Methods: A total of 122 cases of cervical cancer, 35 cases with CIN and 31 cases with uterine fibroids were collected at the Cancer Center of Sun Yat University to determine the expression of beclin I. Results: Beclin l positive rate in normal cervical tissues, CIN tissues and cervical cancers was 83.9%, 74.3% and 53.3%, respectively, and it was significantly different between the three groups (p < 0.01). Beclin 1 expression was negatively correlated with cervical cancer differentiation, lymph node metastasis, recurrence and death (p < 0.05). The negative expression is the risk factor affecting overall survival (p < 0.05) and progression-free survival (PFS) (p < 0.05). Multivariate analysis showed that beclin 1 negative expression was an independent risk factor of PFS time. Conclusions: Beclin I may play a role in the occurrence and development of cervical cancer. Beclin 1 positive expression in patients indicates a better prognosis.
Cervical cancer; Autophagy; Beclin 1; Overall survival (OS); Progression-free survival (PFS)
H.Y. Cheng,Y.N. ZHANG,Q.L. Wu,X.M. Sun,J.R. Sun,X. Huang. Expression of beclin 1, an autophagy-related protein, in human cervical carcinoma and its clinical significance. European Journal of Gynaecological Oncology. 2012. 33(1);15-20.
[1] Valdespino V.M., Valdespino V.E.: “Cervical cancer screening: state of the art”. Curr. Opin. Obstet. Gynecol., 2006, 18, 35.
[2] Abraham M.C., Shaham S.: “Death without caspases caspases without death”. Trends Cell. Biol., 2004, 14, 184.
[3] Lockshin R.A., Zakeri Z.: “Apoptosis, autophagy and more”. Int. J. Biochem. Cell. Biol., 2004, 36, 2405.
[4] Shintani T., Klionsky D.J.: “Autophagy in health and disease: a double-edged sword”. Science, 2004, 306, 990.
[5] Yoshimori T.: “Autophagy. a regulated bulk degradation process inside cells”. Biochem. Biophys Res. Commun., 2004, 313, 453.
[6] Levine B., Yuan J.: “Autophagy in cell death: an innocent convict?”. J. Clin. Invest., 2005, 115, 2679.
[7] Aita V.M., Liang X.H., Murty V.V., Pincus D.L., Yu W., Cayanis E. et al.: “Cloning and genomic organization of beclinl a candidate tumor Suppressor gene on chromosome 17q21”. Genomics, 1999, 59, 59.
[8] Liang X.H., Jackson S., Seaman M., Brown K., Kempkes B., Hib-shoosh H. et al.: “Induction of autophagy and inhibition of tumori-genesis by beclin 1”. Natura1, 1999, 402, 672.
[9] Qu X., Yu J., Bhagat G., Furuya N., Hibshoosh H., Troxel A. et al.: “Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene”. J. Clin. Invest., 2003, 112, 1809.
[10] Yue Z., Jin S., Yang C., Levine A.J., Heintz N.: “Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor”. Proc. Natl. Acad. Sci U S A, 2003, 100, 15077.
[11] Miracco C., Cosci E., Oliveri G., Luzi P., Pacenti L., Monciatti I. et al.: “Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours”. Int. J. Oncol., 2007, 30, 429.[12] Wang Z.H., Xu L., Duan Z.L., Zeng L.Q., Yan N.H., Peng Z.L.: “Beclin 1-mediated macroautophagy involves regulation of caspase-9 expression in cervical cancer HeLa cells”. Gynecol. Oncol., 2007, 107, 107.[13] Duan Z.L., Peng Z.L., Wang Z.H.: “Expression and involved signal transduction pathway of autophagy gene beclin 1 in epithelial ovarian cancer”. Sichuan Da Xue Xue Bao Yi Xue Ban, 2007, 38, 239.
[14] Holm E., Hildebrandt W., Kinscherf R., Droge W.: “Low postabsorptive net protein degradation in male cancer patients: lack of sensitivity to regulatory amino acids?”. Oncol. Rep., 2007, 17, 695.[15] Ma D.: “Tumor and tumor metestasis”. In: Zeng Y.X., Lv Y.Y., Zhu M.H. (eds.). Bei Jing, P.R. China, The people’s Hygienic Publication Society, 2003, 242.
[16] Bursch W., Ellinger A., Kienzl H., Torok L., Pandey S., Sikorska M. et al.: “Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy”. Carcinogenesis, 1996, 17, 1595. [17] Scarlatti F., Bauvy C., Ventruti A., Sala G., Cluzeaud F., Vandewalle A. et al.: “Ceramide -mediated macroautophagy involves inhibition of protein kinase B and up-regulation of beclin 1”. J. Biol. Chem., 2004, 279, 18384.
Top